Ana Regal-Rodriguez

Pontevedra, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.

Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.

Journal: The Annals of pharmacotherapy

Published: January 03, 2026

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

Journal: Frontiers in psychiatry

Published: January 22, 2025

Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Journal: Neurology and therapy

Published: May 29, 2023

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.

Journal: Patient preference and adherence

Published: March 04, 2023

Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

Journal: Multiple sclerosis and related disorders

Published: November 23, 2022

Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources.

Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources.

Journal: Patient preference and adherence

Published: October 08, 2020

Neurological presentations of Bartonella henselae infection.

Neurological presentations of Bartonella henselae infection.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 21, 2018

Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameter.

Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameter.

Journal: Neurologia

Published: June 07, 2017

Myasthenia gravis and treatment with intravenous immunoglobulins. Reply

Myasthenia gravis and treatment with intravenous immunoglobulins. Reply

Journal: Revista de neurologia

Published: October 26, 2016

Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia

Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia

Journal: Revista de neurologia

Published: September 24, 2016

Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis

Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis

Journal: Revista de neurologia

Published: May 06, 2016

Clinical response and tolerability of fampridine in clinical practice.

Clinical response and tolerability of fampridine in clinical practice.

Journal: Neurodegenerative disease management

Published: April 02, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026